Biologic Therapies for Severe Asthma

被引：318
|
作者：
Brusselle, Guy G. [1 ,2 ]
Koppelman, Gerard H. [3 ,4 ]
机构：
[1] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium
[2] Erasmus MC, Dept Epidemiol & Resp Med, Rotterdam, Netherlands
[3] Univ Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp, Univ Med Ctr Groningen, Groningen, Netherlands
[4] Univ Groningen, Groningen Res Inst Asthma & COPD, Univ Med Ctr Groningen, Groningen, Netherlands
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2022年 / 386卷 / 02期
关键词：
SEVERE EOSINOPHILIC ASTHMA; QUALITY-OF-LIFE; DOUBLE-BLIND; MONOCLONAL-ANTIBODY; PRECISION MEDICINE; NASAL POLYPOSIS; MEPOLIZUMAB; PLACEBO; BENRALIZUMAB; EFFICACY;
D O I：
10.1056/NEJMra2032506
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Biologic Therapies for Severe Asthma Patients with severe asthma are at increased risk for a decreased quality of life, fixed airway obstruction, hospitalization, and death. Biologics may be required to reduce the disease burden. This review discusses the mechanisms, efficacy, and safety of biologics for severe asthma.
引用
收藏
页码：157 / 171
页数：15
相关论文
共 50 条
  • [1] Biologic therapies in severe asthma
    Dupin, C.
    [J]. REVUE FRANCAISE D ALLERGOLOGIE, 2023, 63 (03):
  • [2] Severe asthma revisited by biologic therapies emergences
    Guilleminault, Laurent
    Didier, Alain
    [J]. PRESSE MEDICALE, 2019, 48 (03): : 310 - 321
  • [3] Immunomodulatory and biologic therapies for severe refractory asthma
    Polosa, Riccardo
    Morjaria, Jaymin
    [J]. RESPIRATORY MEDICINE, 2008, 102 (11) : 1499 - 1510
  • [4] A pragmatic guide to choosing biologic therapies in severe asthma
    Kavanagh, Joanne E.
    Hearn, Andrew P.
    Jackson, David J.
    [J]. BREATHE, 2021, 17 (04)
  • [5] Clinical remission with biologic therapies in severe asthma: a matter of definition
    Beasley, Richard
    Noble, Jonathan
    Weatherall, Mark
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62 (06)
  • [6] Clinical remission with biologic therapies in severe asthma: a matter of definition
    McDowell, P. Jane
    McDowell, Ron
    Busby, John
    Eastwood, M. Chad
    Patel, Pujan H.
    Jackson, David J.
    Mansur, Adel
    Patel, Mitesh
    Burhan, Hassan
    Doe, Simon
    Chaudhuri, Rekha
    Gore, Robin
    Dodd, James W.
    Subramanian, Deepak
    Brown, Thomas
    Heaney, Liam G.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2024, 63 (06)
  • [7] Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies
    Katial, Rohit K.
    Bensch, Greg W.
    Busse, William W.
    Chipps, Bradley E.
    Denson, Joshua L.
    Gerber, Anthony N.
    Jacobs, Joshua S.
    Kraft, Monica
    Martin, Richard J.
    Nair, Parameswaran
    Wechsler, Michael E.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (02): : S1 - S14
  • [8] Biologic therapies for asthma
    Gruenberg, David
    Busse, William
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2010, 16 (01) : 19 - 24
  • [9] Biologic therapies for severe asthma with persistent type 2 inflammation
    Chandrasekara, Sahan
    Wark, Peter
    [J]. AUSTRALIAN PRESCRIBER, 2024, 47 (02) : 36 - 42
  • [10] ADRENAL INSUFFICIENCY IN SEVERE ASTHMA: AN EMERGING PROBLEM IN THE ERA OF BIOLOGIC THERAPIES
    Raheem, A.
    Green, L.
    Fernandes, M.
    Roxas, C.
    d'Ancona, G.
    Kavanagh, J.
    Kent, B. D.
    Jackson, D. J.
    [J]. THORAX, 2018, 73 : A174 - A174
12345